1.77BMarket Cap-8637P/E (TTM)
25.825High24.650Low859.36KVolume24.680Open24.720Pre Close21.70MTurnover1.50%Turnover RatioLossP/E (Static)70.84MShares26.42852wk High4.71P/B1.44BFloat Cap4.22052wk Low--Dividend TTM57.49MShs Float52.380Historical High--Div YieldTTM4.75%Amplitude4.220Historical Low25.250Avg Price1Lot Size
Nurix Therapeutics Stock Forum
as this guy 👇
$Taysha Gene Therapies (TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals (TFFP.US)$ 14% Clinical programs update
$Jaguar Health (JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin (SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems (DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences (SLS.US)$ 0% Closes $20M offering & private placement
$Immunic (IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics (NRIX.US)$ 0...
Nurix said patients currently enrolled in the trial who are deriving clinical benefit are allowed to continue receiving the current drug product. The screening and enrollment of new patients has been paused.
The company sai...
No comment yet